IDiyas

For the Inventor, By the Inventor

Paris, France

Gilbert Marciniak

USPTO Granted Patents = 10

 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:

goldMedal10 out of 1,451 
 
Sanofi
 patents

Years Active: 2012-2023

Loading Chart...
Loading Chart...
10 patents (USPTO):
1. 11739100 - 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof (2023-08-29),
2. 10253043 - 2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof (2019-04-09),
3. 9321790 - Pyrimidinone derivatives as antimalarial agents (2016-04-26),
4. 9120812 - Pyrimidooxazocine derivatives as mTOR-inhibitors (2015-09-01),
5. 8846670 - 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof (2014-09-30),
6. 8846654 - Therapeutic applications in the cardiovascular field of quinazolinedione derivatives (2014-09-30),
7. 8828997 - 2,3-dihydro-1H-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof (2014-09-09),
8. 8748441 - Therapeutic uses of quinazolinedione derivatives (2014-06-10),
9. 8722659 - Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof (2014-05-13),
10. 8242126 - Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof (2012-08-14),

Title: Gilbert Marciniak: Innovator in Pharmaceutical Chemistry

Introduction

Gilbert Marciniak is a prominent inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work focuses on developing novel compounds with potential therapeutic applications.

Latest Patents

Among his latest patents are the 2,3-dihydro-1H-imidazo{1,2-a}pyrimidin-5-one and 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives. These compounds include a substituted morpholine and are designed for pharmaceutical use, particularly as anticancer medications. The inventions relate to novel products with specific chemical formulas, showcasing his expertise in medicinal chemistry.

Career Highlights

Gilbert Marciniak is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on innovative drug development, contributing to advancements in cancer treatment.

Collaborations

He has collaborated with notable colleagues, including Bertrand Vivet and Bruno Filoche-Romme. These partnerships have enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Gilbert Marciniak's contributions to pharmaceutical chemistry and his innovative patents underscore his role as a key figure in the development of new therapeutic agents. His work continues to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…